Skip to content

The latest step in our journey: NuChem Sciences

Since 2022 we have enhanced our capabilities, expanded our reach and strengthened our overall position in the industry: first in the North American market, through joining the NuChem Sciences group of companies and, more recently, by expanding into a global market when we joined the Sygnature Discovery Group.

We are excited to share the latest news here at IniXium as we reach the final stages of our global integration.

What’s changing?

While our clients will not see any change in how we work on our scientific projects, we will be making administrative changes – the first changes in April 2024 and the second over summer 2024.

What will not change?

We know that our success is intrinsically linked to the trust and support of our clients give us when they partner with us on their projects. Our commitment to providing exceptional services and innovative solutions remains unwavering throughout this process. The integration changes will, not only streamline our operations, but also strengthen our capabilities at the forefront of drug discovery, positioning us to better serve our customer’s evolving needs. 

What can you expect as a customer?

From the start of April, you will begin to receive communications and invoices from us under the name “NuChem Sciences”. Our contract with you will also be updated with the NuChem Sciences name. 

We thank you in advance for letting your legal and finance teams know about the name change. 

To note, while our bank account details will be updated in the future, your finance team will not need to change any of the bank account details at this stage. 

Do you have any questions? 

Should you have any questions or concerns regarding these changes, please do not hesitate to contact us. 


We value your partnership and look forward to continuing our successful collaboration under the enhanced NuChem Sciences and Sygnature Discovery brand.